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Abstract
Objective: Transmission patterns of drug-resistant Mycobacterium tuberculosis (MTB) may be influenced by differences in
socio-demographics, local tuberculosis (TB) endemicity and efficaciousness of TB control programs. This study aimed to
investigate the impact of DOTS on the transmission of drug-resistant TB in eastern rural China.
Methods: We conducted a cross-sectional study of all patients diagnosed with drug-resistant TB over a one-year period in
two rural Chinese counties with varying lengths of DOTS implementation. Counties included Deqing, with over 11 years’
DOTS implementation and Guanyun, where DOTS was introduced 1 year prior to start of this study. We combined
demographic, clinical and epidemiologic information with IS6110-based restricted fragment length polymorphism (RFLP)
and Spoligotyping analysis of MTB isolates. In addition, we conducted DNA sequencing of resistance determining regions to
first-line anti-tuberculosis agents.
Results: Of the 223 drug-resistant isolates, 73(32.7%) isolates were identified with clustered IS6110RFLP patterns. The
clustering proportion among total drug-resistant TB was higher in Guanyun than Deqing (26/101.vs.47/122; p,0.04), but not
significantly different among the 53 multidrug-resistant isolates (10/18.vs.24/35; p,0.35). Patients with cavitary had increased
risk of clustering in both counties. In Guanyun, patients with positive smear test or previous treatment history had a higher
clustering proportion. Beijing genotype and isolates resistant to isoniazid and/or rifampicin were more likely to be clustered.
Of the 73 patients with clustered drug-resistant isolates, 71.2% lived in the same or neighboring villages. Epidemiological
link (household and social contact) was confirmed in 12.3% of the clustered isolates.
Conclusion: Transmission of drug-resistant TB in eastern rural China is characterized by small clusters and limited
geographic spread. Our observations highlight the need for supplementing DOTS with additional strategies, including
active case finding at the village level, effective treatment for patients with cavities and drug susceptibility testing for
patients at increased risk for drug-resistance.
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Introduction
Drug-resistant Mycobacterium tuberculosis (MTB) once confined
to hospitals and institutional settings,is now widespread in some
communities and stands to undermine global tuberculosis
control efforts. Of particular concern is the occurrence of
multidrug-resistant tuberculosis (MDR-TB), defined as resis-
tance to at least isoniazid and rifampicin. MDR-TB patients
respond poorly to conventional first-line therapy, are costly to
manage, and typically remain infectious for prolonged periods
of time due to inefficient bacillary clearance [1,2,3]. Clearly, a
better understanding of drug-resistant TB epidemiology is
paramount to inform evidence-based control strategies for
MDR-TB.
Drug-resistance is associated with a number of factors
including poor adherence to anti-TB treatment[4]. MDR-TB
comes about as a result of the stepwise accumulation mutations in
drug-resistance conferring genes. Previously, drug-resistant MTB
strains were thought to be less infectious and less likely to cause
disease when compared to their drug-susceptible counterparts
[5]. However, recent studies have shown that they are able to
transmit and cause disease as often as drug-susceptible organisms
[6,7,8]. In addition to de novo acquisition, primary transmission
of already resistant organisms may be fueling the ongoing MDR-
TB epidemic [9,10].
Directly observed treatment, short course (DOTS) is a cost-
effective strategy to control TB, where standardized chemotherapy
observed by trained health providers is the key element for
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er, MDR-TB cases are increasingly reported in DOTS-covered
areas [10,11,12]. In China, DOTS-based TB control programs
have been implemented comprehensively since its introduction
over 15 years ago and by 2007 DOTS coverage in China had
reached almost 100% [13]. Despite DOTS penetration, there
remains significant increase in prevalence of MDR-TB particu-
larly in rural areas. China is considered one of the ‘‘hotspot’’
regions for drug-resistant TB by WHO [14] and accounts for a
quarter of the global burden.
A recent study conducted in eastern rural China reported a
significantly higher proportion of MDR-TB in regions with long-
term DOTS coverage when compared to short-term DOTS
covered areas [15]. In addition, drug-resistant MTB circulating in
these communities in rural China was strongly associated with
specific resistance conferring mutations [16]. Furthermore, a
major subgroup within the Beijing family[17] and strains with
katG315T [18] possess an increased predisposition to develop
MDR and transmission in rural China. Based on these
observations, we sought to systematically determine the extent of
transmission of drug-resistant MTB in these two counties, with
varied lengths of DOTS implementation. Furthermore, we
examined transmission of drug-resistant TB at the phenotypic
and genotypic level, explored risk factors for the recent
transmission, as well as assessed relative geographic distances
between patients infected with ‘‘clustered’’ MTB IS6110 RFLP
genotypes in two counties, in an attempt to provide the knowledge
base to understand the epidemic of drug-resistant TB as well as to
inform TB control activities in rural China.
Materials and Methods
The study was approved by the Institutional Review Board of
Fudan School of Public Health. Written informed consent was
obtained from all the participants.
Study sites
Jiangsu Province and Zhejiang Province are located in eastern
China and border each other. Two counties Deqing and Guanyun
were selected separately from these two provinces as the study
sites. The selection of study sites was based on the comparable
socioeconomics, demographics, general health systems, capacity
and willingness of local partners. While Deqing implemented the
DOTS-based National TB Control Program guidelines 11 years
ago, Guanyun adopted the DOTS strategy less than 1 year prior
to start of this study. In both counties, the county TB dispensary is
the only designated health facility for TB diagnosis, treatment and
case management. Due to limited resources, bacterial culturing
and drug susceptibility testing (DST) were not routinely per-
formed. TB treatment was based on the standardized therapy
using 1
st-line anti-TB agents.
Bacterial isolates and clinical data
In this population-based epidemiological study, a total of 399
diagnosed pulmonary TB patients, 182 in Deqing and 217 in
Guanyun, registered at local TB dispensaries during 12 months
consecutive in 2004–2005 were enrolled. All patient specimens at
TB dispensaries were submitted to the microbiology laboratory in
School of Public Health, Fudan University for culturing and
identification. After identification by implanting colonies separate-
ly in PNB and TCH containing culture media, 387 isolates was
defined as MTB by presenting TCH positive and PNB negative.
MTB isolates were further examined for their susceptibilities to
isoniazid (INH), streptomycin (STR), ethambutol (EMB) and
rifampicin (RIF) by proportion method [19]. Results from
culturing and drug susceptibility testing as well as demographic
and clinic information were available for 164 (90.1%) isolates in
Deqing and 187 (86.2%) isolates in Guanyun, respectively. These
MTB isolates were included in the present study.
Genotyping
Genotyping was performed on each isolate using both IS6110-
based Restricted Fragment Length Polymorphism (RFLP) and
Spoligotyping. IS6110 RFLP was performed according to methods
described by van Embden and coworkers [20]. Briefly, chromo-
somal DNA was digested with restriction endonuclease PvuII and
hybridized with a probe prepared from a 245-bp PCR product of
IS6110.I S 6110 Southern blot hybridization pattern was visualized
using a commercial kit (Maarssen, The Netherlands). The DNA
fingerprint patterns of the isolates were compared both by
Gelcompar software (version 3.lb, Applied Maths, Kortrijk,
Belgium) and by visual examination. A molecular ‘‘cluster’’ was
defined as two or more persons whose organisms had identical
IS6110 RFLP patterns, while the organisms with orphan IS6110
RFLP pattern was defined as ‘‘unique’’ strain. Typically, clustered
strains indicate recent transmission while unique strains indicate
reactive disease from a remote infection.
Spoligotyping was performed to differentiate the Beijing family
from other genotypes. The spacer between the direct repeats in the
target region was amplified using two 18 bp nucleotide primers as
described elsewhere [21]. The PCR products were hybridized to
commercial membrane (Isogen Bioscience BV, Maarssen, The
Netherlands). Hybridized DNA was detected using an enhanced
chemiluminescene kit from Isogen Bioscience BV (Maarssen, The
Netherlands), which resulted in patterns for each strain reminis-
cent of a ‘barcode’. Strain family was determined by comparing
Spoligotyping patterns with the SpoligDB4 database [21]. Beijing
family MTB was defined as those hybridizing the last nine spacer
oligonucleotides (spacers 35 to 43) of the Spoligotyping pattern.
DNA sequencing
We targeted the 59 and 39 flanking resistance determining
regions of rpoB(Genebank assession No.L27989), katG(Genebank
Table 1. Demographic and clinic characteristics of patients
and drug-resistant patterns at diagnosis in Deqing and
Guanyun.
Variables
Deqing
(n=164)
Guanyun
(n=187) x
2 p
No. % No. %
Male (sex) 109 66.5 128 68.4 0.157 0.69
Age (mean6SD) 48.44618.96 48.20619.76 0.045
a 0.83
Cavity 22 13.4 33 17.6 1.184 0.28
Smear positive 110 67.1 129 69.0 0.147 0.70
BMI value (mean6SD) 18.3362.62 18.9063.00 3.579
a 0.06
Previously treated 42 25.6 51 27.3 0.124 0.73
Drug-resistant pattern at diagnosis
Pan-drug sensitive 63 38.4 65 34.8 4.089 0.13
MDR-TB 18 11.0 35 18.7
Other drug-resistance 83 50.6 87 46.5
aF value for ANOVA test.
doi:10.1371/journal.pone.0019548.t001
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embB(Genebank assession No.U68480), using oligonucleotide
primers previous described[16]. Targeted PCR products were
sequenced using an Applied Biosystem 3730/37306l DNA
analyzer. DNA sequencing data was aligned manually using
Sequencer 4.7 software (Gene Codes Corporation). All the
nucleotide data has been submitted and deposited in GenBank.
Statistical analysis
Descriptive analyses were performed using SPSS 11.0 (SPSS,
Chicago, IL, USA). ANOVA and x2tests were used to examine
difference in baseline information between the two rural counties.
Univariate and multivariate analysis were conducted using binary
logistic regression model. Odds ratio (OR) and 95% confidence
interval (CI) were reported after adjusting for age, sex and
Figure 1. The clustering patterns of IS6110 RFLP and their distribution in counties and 1st-line drug susceptibilities groups. The
isolates in the counties represented the clustered drug-resistant MTB with the identical IS6110 RFLP patterns.
doi:10.1371/journal.pone.0019548.g001
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less.
Results
Detailed characteristics of studied patients and the drug-resistant
pattern and the genetic mutation of MTB isolates have been
reported previously [15,16]. Summary characteristics of subjects
were shown in Table 1. No statistically significant differences were
observed in the socio-demographic and clinical features of patients
from the two counties.
Of the 223 drug-resistant MTB isolates, a total of 180 IS6110
RFLP genotype patterns were observed, with 30 clusters
composed of 73 drug-resistant isolates (32.7%). Of these clusters,
19 clusters were composed solely by 40 drug-resistant isolates, and
the other 11 clusters were shared with 33 drug-resistant and 15
pan-drug sensitive isolates. The remaining 150 drug-resistant
isolates (67.3%) gave the unique fingerprint patterns. A total of 12
and 21 clusters were observed in Deqing and Guanyun, with three
IS6110 RFLP patterns shared between the two counties. The
clustering proportion of drug-resistant TB was significantly higher
in Guanyun than that in Deqing (26/101.vs.47/122; p, 0.04), but
there was no significant difference for MDR-TB (10/18.vs.24/35;
p, 0.35) (Figure 1). Results from Spoligotyping showed that 163
(73.1%) isolates belonged to Beijing family. Spoligotype-based
lineages for 46 of the remaining 60 isolates were as follows: Family
33 (17/223 or 7.6%), T lineage (15/223 or 6.7%), Haarlem (5/
223 or 2.2%), LAM (8/223 or 3.6%) and EAI (1/223 or 0.4%).
Twelve isolates shared identical Spoligotyping patterns, of which 2
were in family 33 shared Spoligotyping International Type (SIT)
54 (Octal value 7777 7777 7763 771), 2 and 4 isolates in T1 shared
SIT 52(Octal 7777 7777 7760 731) and SIT53 (Octal value 7777
7777 7760 771), 2 and 2 in LAM family shared SIT 1755 (Octal
6777 7760 7560 771) and new SIT(Octal value 7777 7760 3560
731) (Table S1).
Results from the multivariate analysis are shown in Table 2.
Stratified by county, drug-resistant isolates within Beijing family
had a significantly higher clustering proportion than those from
the other strain families (Deqing: OR, 6.18; 95%CI, 1.332–28.64;
Guanyun: OR, 3.75; 95%CI, 1.396–10.06). Drug-resistant isolates
from the patients with cavitary disease were more likely to be
clustered than those without cavitation (Deqing: OR, 4.50;
95%CI, 1.421–14.26; Guanyun: OR, 2.85; 95%CI:1.195 –
6.782). In Guanyun, previous treatment history (OR, 5.66;
95%CI, 2.332–13.73) and positive sputum smear status (OR,
2.98; 95%CI, 1.191–7.441) were independently associated with
clustering among drug-resistant MTB isolates (Table 2).
Clustering proportion among drug-resistant MTB isolates was
compared to the 128 drug-susceptible MTB isolates collected
simultaneously. Isolates resistant to INH (48.1%.vs. 30.5%; p,
0.008; OR, 2.01; 95%CI, 1.204–3.369), RIF (53.8%.vs.30.5%; p,
0.003; 2.62; 95%CI, 1.382–4.980) and MDR-TB (64.2%.vs.
30.5%; p, 0.0001; OR, 3.87; 95%CI, 1.924–7.764) were more
likely to be clustered compared to drug-susceptible isolates
(Table 3). The association between drug-resistance conferring
genotype and clustering was investigated by comparing the
clustering proportion between drug-resistant genotype and wide
type isolates. Among INH resistant isolates, katG 315Thr alleles
(73.0%.vs18.0%; p, 0.0001; OR, 12.7; 95%CI: 6.357–14.80) were
strongly associated with clustering. No other alleles conferring
resistance to RIF, STR and EMB were associated with clustering.
Epidemiological links within drug-resistant clusters and geo-
graphic distribution based on patients’ residence are depicted in
Figure 2. Of the 30 clusters (i.e. identical IS6110 RFLP patterns), 9
Table 2. Univariate and multivariate analysis on the factors influencing the clustering proportion of drug-resistant TB (n=223).
Variable Deqing county Guanyun county
Total Clustered cOR aOR
a p
a 95%CI
a Total Clustered cOR aOR
a p
a 95%CI
a
BMI
.18.5 51 10 (19.6) 1.00 1.00 58 19(32.8) 1.00 1.00
#18.5 50 16 (32.0) 1.93 1.92 0.17 0.760–4.820 64 28(43.8) 1.60 1.77 0.15 0.818–3.840
TB contact
No 88 22 (25.0) 1.00 1.00 92 34(37.0) 1.00 1.00
Yes 13 4 (30.8) 1.33 1.38 0.63 0.382–4.963 30 13(43.3) 1.30 1.37 0.48 0.579–3.235
Sputum smear test
negative 28 6 (21.4) 1.00 1.00 38 8 (21.1) 1.00 1.00 0.02
positive 73 20(27.4) 1.38 1.38 0.54 0.488–3.910 84 39(46.4) 3.25 2.98 0.01
b 1.191–7.441
Cavity
No 86 18(20.9) 1.00 1.00 92 30(32.6) 1.00 1.00
Yes 15 8 (53.3) 4.32 4.50 0.01
b 1.421–14.26 30 17(56.7) 2.70 2.85 0.02
b 1.195–6.782
Treatment history
New 68 17(25.0) 1.00 1.00 79 21(26.6) 1.00 1.00
Prior treated 33 9 (27.3) 1.13 1.14 0.78 0.443–2.945 43 26(60.5) 4.22 5.66 0.01
b 2.332–13.73
Strain family
Non-Beijing 27 2 (7.4) 1.00 1.00 33 6(18.2) 1.00 1.00
Beijing genotype 74 24(32.4) 6.00 6.18 0.02
b 1.332–28.64 89 41(46.1) 3.84 3.75 0.01
b 1.396–10.06
aOR and 95% CI was adjusted for age and sex in the binary logistics regression model.
bp,0.05.
doi:10.1371/journal.pone.0019548.t002
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originating from the same or neighboring village in the same town.
The town central of Deqing and Guanyun contained 5 and 6
clusters respectively, involving 8 and 13 drug-resistant patient
isolates. The isolates from the 3 clusters in Deqing and 5 clusters in
Guanyun were obtained from different localities. From potential
contact perspective, 4 of 26 (15.4%) clustered isolates from Deqing
and 5 of 47 (10.6%) clustered isolates from Guanyun were
obtained from family members (household contact), friends or
working colleagues (social contact). No epidemiological links or
geographic correlation was established for 9 clustered drug-
resistant isolates (34.6%) in Deqing and 11 clustered drug-resistant
isolates (23.4%) in Guanyun.
Discussion
Transmission patterns of drug-resistant MTB has been well
documented in low TB incidence countries, however there is
paucity of reports from high TB burden countries like China; this
information could be very important in decision-making for TB
control. To that end, the present study aimed to describe the
transmission of drug-resistant TB in two comparable rural Chinese
communities withdifferent duration of DOTS implementation, and
to identify risk factors for developing appropriate strategies for
prevention and control of drug-resistant TB in eastern rural China.
IS6110 DNA fingerprinting indicated that the degree of MTB
genotypic heterogeneity did not vary significantly between Deqing
and Guanyun, with 87 and 86 IS6110 RFLP patterns respectively.
This may be expected given the overwhelming dominance of the
Beijing family strain in most regions in China [17,22]. In addition
to its overall prevalence, Beijing family members are increasingly
found associated with MDR-TB [23,24] and enhanced transmis-
sibility in some areas [25,26]. Similarly in the present study, the
majority (73.1%) of drug-resistant TB were from members of the
Beijing family. Drug-resistant TB isolates within Beijing family
showed a relatively high level of clustering (40.0%), suggesting
active transmission. Furthermore, three Beijing IS6110 RFLP
clusters were simultaneously observed in Deqing from Zhejiang
Province and Guanyun from Jiangsu Province, possibly due to its
inter-provincial transmission. This tendency may suggest high
transmissibility potential for some specific members of Beijing
family [17]. The active transmission of such subgroups may
Table 3. Clustering proportion between the MTB isolates with different drug-resistant pattern and genetic mutation (n=223).
No.of isolates crude Adjusted OR
b p
b 95%CI
b
Total Clustered(%) OR
a
Isolates resistant to:
Sensitive 128 39(30.5) 1.00 1.00
INH 131 63(48.1) 2.05 2.01 0.008
c 1.204–3.369
RIF 65 35(53.8) 2.66 2.62 0.003
c 1.382–4.980
STR 115 26(22.6) 0.67 0.68 0.19 0.376–1.215
EMB 42 12(28.6) 0.91 0.90 0.79 0.405–1.988
MDR-TB 53 34(64.2) 4.08 3.87 0.0001
c 1.924–7.764
Other combinations 170 39(22.9) 0.82 0.82 0.15 0.634–1.070
Drug-resistant isolates with mutation in:
katG
wt 50 9 (18.0) 1.00 1.00
others 7 0 (0) - - - -
315Thr 74 54(73.0) 12.3 12.7 0.0001
c 6.357–14.80
rpoB
wt 5 1(20.0) 1.00 1.00
others 23 10 (43.5) 4.22 4.88 0.12 0.597–19.298
531Leu 37 24 (64.9) 8.71 8.50 0.08 0.771–93.65
rpsL
wt 37 9 (24.3) 1.00 1.00
others 18 2 (11.1) 0.33 0.55 0.49 0.099–3.035
43Arg 60 15(25.0) 1.04 1.41 0.51 0.511–3.865
embB
wt 21 5(23.8) 1.00 1.00
306lle 8 2(25.0) 1.27 1.19 0.87 0.164–8.584
306Val 13 5(38.5) 1.80 1.59 0.14 0.673–9.100
Note: INH,isoniazid; RIF,rifampicin; STR, streptomycin; EMB, ethambutol.
acOR: crude odds ratio were calculated by comparing the clustering proportion between drug- resistant MTB isolate and drug-susceptible isolate in binary logistic
regression model.
baOR: adjusted odds ratio and 95%CI were calculated by comparing the clustering proportion between drug-resistant TB isolate and drug-susceptible isolate, adjusted
by age, sex, and counties of the subjects in a binary logistic regression model.
cp,0.05.
doi:10.1371/journal.pone.0019548.t003
Transmission of Drug-Resistant TB in Rural China
PLoS ONE | www.plosone.org 5 May 2011 | Volume 6 | Issue 5 | e19548contribute to the ongoing epidemic of drug-resistant TB in rural
China and highlights the need for better control measures to
prevent the primary transmission.
In Guanyun, a county with recent DOTS implementation, most
clusters were among cases with previous treatment history. In
addition, cavitary lesions and sputum smear positivity (indicating
infectiousness) were significantly more common among the drug-
resistant cases with clustered genotypes than those infected with
unique genotypes. Our findings are consistent with those reported
by others [27,28]. Typically, patients with cavitary disease harbor
higher bacillary burdens, thereby increasing the likelihood of
selecting mutants during therapy [29,30]. Smear positivity would
similarly indicate higher bacillary burden and increased infec-
tiousness. The high proportion of clustering pattern in previously
treated cases is also troubling as it indicates that inadequate
previous treatment increasing the risk of drug-resistance and
primary transmission. While in Deqing where DOTS had been
implemented for over 15 years, only patients with cavities had
increased risk for clustering. Previous treatment history wasn’t
found a risk factor for clustering as it was in Guanyun County.
The differences between the counties might indicate population-
level effects of long-term regulated and standardized TB treatment
(i.e. DOTS). However, we did not observe the significant
difference in the clustering proportion among MDR-TB isolates
between two counties, suggesting that without routine bacterio-
logic-based diagnosis and drug susceptibility testing and without
regulated treatment for drug-resistant TB, DOTS itself might not
be able to prevent the risk of community-level MDR-TB
transmission. Therefore, MDR-TB control programs in China
may be modified according to local settings and needs additional
Figure 2. The geographic distribution of the patients with the clustered MTB isolates in Deqing(upper) and Guanyun(lower). Note:
cottage represented the township; vile represented the central area of the counties; No. marked the IS6110 RFLP clusters; the underlined No.
represented the drug-susceptible MTB isolates; Eclipse marked the clustered isolates distributed in the same township; the dotted line connected the
clustered isolate without geographic correlation.
doi:10.1371/journal.pone.0019548.g002
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risk of drug-resistant TB, improving ability of diagnosis for drug-
resistance in TB clinics and hospitals, and providing individualized
treatment for drug-resistant TB patients.
Resistance to anti-TB drugs can develop as a result of treatment
failure (acquired resistance), but it can also occur as a result of
infection with drug-resistant strains (primary resistance). Among
drug-resistant TB patients in our study, INH resistant, RIF
resistant and MDR-TB had a significantly higher clustering
proportion compared to the drug-susceptible MTB isolates,
highlighting the significance of the primary resistance. Compara-
bly, the reactivation from the remote infection might be the main
reason for the STR and EMB resistance. A high clustering
proportion of katG315Thr allele was observed in this study. This
allele was associated with MDR-TB as reported elsewhere
[18,31,32]. Therefore, this allele may be the major genotype
responsible for the recent transmission of MDR-TB and INH
resistant strain in the studied areas. The different epidemic
mechanism for drug-resistant TB implies that tailored strategies
are needed for in control of drug-resistant TB. Considering the
transmissibility of INH and RIF resistant TB, susceptibility testing
of INH and RIF should be provided, and fast diagnosis of drug-
resistance is paramount.
The geographic distribution of isolates from clusters containing
drug-resistant TB is consistent with the distribution of rural
population. Most clones of drug-resistant strains were found to
infect small groups of patients. This suggests that active
transmission of drug-resistant MTB strain may be limited in
Chinese rural communities. Furthermore, a relative high propor-
tion of patients in the clusters lived in the same or neighboring
villages. TB patients are usually weak and unable to work, and
they have to take treatment for 6–8 months at home. Thus, the
scope of their activity is limited, especially in rural China, which
might limit the contacts within the same village and makes
transmission circle restricted at the village and neighborhood level.
Although clusters came from a wide geographic area, a high
level of clustered MTB isolate was observed in the central districts.
The central district in rural China commonly has the highest
population density and also serves as centers for cultural and social
activities. Furthermore, the central districts contain county-level
hospitals and TB dispensaries for the diagnosis and treatment of
TB. These conditions in central areas may facilitate transmission
of MTB. In addition, the present study also noted clustered isolates
scattered from different localities, where no clear epidemiological
link was identified. Lack of epidemiological links, in the context of
clustering, may indicate the existence of wide spread endemic
MTB strains. Of note, our one-year study period as well as the
passive case detection strategies may have missed intermediate
cases in the transmission chain. Our primary genotyping method,
IS6110 RFLP has long served as a gold standard technique with
highest discriminatory power for high-copy number isolates
including Beijing genotype isolates. However, some recent studies
have pointed to clustering misclassification using IS6110 RFLP
alone [33,34,35]. Therefore to better define the genotypes of MTB
in certain settings, the future studies may benefit from combining
IS6110 RFLP with alternative genotyping methods such as 24-loci
variable number tandem repeat analysis.
Adoption of DOTS to prevent the generation of drug-resistant
strains and careful introduction of second-line drugs to treat
patients with MDR-TB are the top priorities for proper
containment of MDR-TB. As reported above in rural China,
the transmission pattern of drug-resistant TB was sporadic
distribution and in small groups. The spread of drug-resistance
may be restricted due to limited social activity of rural populations.
Based on our data, anti-TB intervention should focus mainly on
individuals proximal to the infectious TB case, rapid identification
of drug-resistance, and include active case finding strategies.
Supporting Information
Table S1 Spoligotyping pattern and drug-resistant pattern and
genetic mutation of drug-resistant MTB isolates with non-Beijing
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